Market Overview

UPDATE: J.P. Morgan Reiterates Overweight Rating, Lowers PT on Agilent Technologies on F1Q13 Review

Related A
Pressure Biosciences CEO On Its Beaten Down Stock: 'We Can Now Begin To Focus On The Area That Is Most Important'
The Market In 5 Minutes: DryShips, Trump And Target
Cancer Immunotherapy Market: 2016 Takeaways And What To Expect In 2017 (Seeking Alpha)

In a report published Friday, J.P. Morgan reiterated its Overweight rating on Agilent Technologies (NYSE: A), but slightly lowered its price target from $51.00 to $50.00.

J.P. Morgan noted, “As a diversified supplier to the life sciences, chemical analysis, and electronic test & measurement industries, Agilent should continue to benefit from favorable long-term trends in EMG and above-market growth in both LSG and CAG, driven by higher than average investments in R&D, a strong footprint in faster growing markets (i.e., China), and synergies from recent acquisitions (i.e., Varian and Dako).”

Agilent Technologies closed on Thursday at $44.58.

Latest Ratings for A

Nov 2016Leerink SwannAssumesOutperform
Aug 2016Goldman SachsMaintainsBuy
Aug 2016Evercore ISI GroupMaintainsBuy

View More Analyst Ratings for A
View the Latest Analyst Ratings

Posted-In: J.P. MorganAnalyst Color Price Target Analyst Ratings


Related Articles (A)

View Comments and Join the Discussion!